Hemoglobin Oxygen Therapeutics LLC (HOTI)

Hemoglobin Oxygen Therapeutics LLC will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Chart not available yet
Data will show when the stock starts trading.
Market Cap n/a
Revenue (ttm) n/a
Net Income (ttm) -6.13M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About HOTI

Hemoglobin Oxygen Therapeutics is a biotechnology company focused on the development, manufacture, and commercialization of a proprietary technology platform for oxygen-carrying solutions that address critical unmet medical needs in both human and veterinary medicine. Using our patents, proprietary technology and know-how, we develop and sell products that, under certain conditions, are a possible alternative to blood transfusions to deliver oxygen to organs and tissues. Through numerous clinical studies, our products have been shown to address... [Read more]

Industry Health Care
Sector Biotechnology
Founded 2014
Employees 10
Stock Exchange NASDAQ
Ticker Symbol HOTI
Full Company Profile

Financial Performance

Financial Statements


Hemoglobin Oxygen Therapeutics IPO Registration Document (S-1)

Hemoglobin Oxygen Therapeutics has filed to go public with an IPO on the NASDAQ.

2 years ago - SEC